Sanofi (SNY)
NASDAQ:SNY
Holding SNY?
Track your performance easily

Sanofi (SNY) Income Statement

1,822 Followers

Sanofi Income Statement

Last quarter (Q4 2023), Sanofi's total revenue was €―, a decrease of -100.00% from the same quarter last year. In Q4, Sanofi's net income was €―. See Sanofi’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 23.88B€ 46.44B€ 43.00B€ 37.82B€ 37.37B€ 37.63B
Cost of Revenue
€ 7.08B€ 14.24B€ 13.70B€ 12.26B€ 12.16B€ 11.98B
Gross Profit
€ 16.80B€ 32.21B€ 29.30B€ 25.56B€ 25.21B€ 25.66B
Operating Expense
€ 9.88B€ 24.00B€ 22.59B€ 18.64B€ 17.32B€ 18.43B
Operating Income
€ 6.92B€ 8.20B€ 6.71B€ 6.92B€ 7.89B€ 7.23B
Net Non Operating Interest Income Expense
€ -128.00M€ -722.00M€ 129.00M€ 40.00M€ -335.00M€ -304.00M
Other Income Expense
€ -2.77B€ -1.16B€ -19.38B€ -15.85B€ 6.22B€ -4.10B
Pretax Income
€ 4.03B€ 7.15B€ 28.49B€ 24.57B€ 13.78B€ 2.82B
Tax Provision
€ 764.00M€ 1.72B€ 2.01B€ 1.56B€ 1.81B€ 139.00M
Earnings From Equity Interest Net Of Tax
€ 35.00M-€ 68.00M€ 106.00M€ 359.00M€ 255.00M
Net Income Common Stockholders
€ 3.25B€ 5.40B€ 26.60B€ 23.02B€ 12.29B€ 2.81B
Basic EPS
-€ 4.31-€ 4.97--
Diluted EPS
-€ 4.30-€ 4.95--
Basic Average Shares
-€ 1.25B€ 1.25B€ 1.25B--
Diluted Average Shares
-€ 1.26B€ 1.25B€ 1.25B--
Dividend Per Share
-€ 3.76€ 3.91---
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
€ 16.96B€ 38.24B€ 36.29B€ 30.90B€ 29.48B€ 30.41B
Net Income From Continuing And Discontinued Operation
€ 3.25B€ 5.40B€ 26.60B€ 23.02B€ 12.29B€ 2.81B
Normalized Income
€ 5.38B---€ 7.00B€ 7.12B
Interest Expense
€ 204.00M---€ 434.00M€ 469.00M
EBIT
€ 4.23B-€ 27.84B€ 23.84B€ 14.21B€ 3.29B
EBITDA
€ 5.15B-€ 29.89B€ 25.34B€ 17.88B€ 10.74B
Currency in EUR

Sanofi Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis